STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENTA
  4. [ARS] ENANTA PHARMACEUTICALS INC SEC Filing

[ARS] ENANTA PHARMACEUTICALS INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - ENANTA PHARMACEUTICALS INC

ARS Filing - ENANTA PHARMACEUTICALS INC

This filing is available as a PDF document.

Filing Type: ARS

Company: ENANTA PHARMACEUTICALS INC (ENTA)

Acceptance Date: 2026-01-26T16:12:07.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Enanta Pharmaceuticals Inc

NASDAQ:ENTA

View ENTA Stock Overview →

ENTA Rankings

#3704 Ranked by Market Cap
N/A Ranked by Dividends

ENTA Latest News

Mar 3, 2026
Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference
Feb 10, 2026
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
Feb 9, 2026
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
Jan 8, 2026
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
Jan 5, 2026
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

ENTA Latest SEC Filings

Mar 13, 2026
[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity
Mar 13, 2026
[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity
Mar 13, 2026
[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity
Mar 13, 2026
[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity
Mar 13, 2026
[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity

ENTA Stock Data

389.15M
27.61M
Biotechnology
Pharmaceutical Preparations
Link
United States
WATERTOWN